Volume 30, Number 11—November 2024
Dispatch
Fatal Oropouche Virus Infections in Nonendemic Region, Brazil, 2024
Table 3
Laboratory test |
Patient 1 |
Patient 2 |
---|---|---|
qRT-PCR | ||
Dengue virus | Undetectable | Undetectable |
Chikungunya virus | Undetectable | Undetectable |
Zika virus | Undetectable | Undetectable |
Mayaro virus | Undetectable | Undetectable |
Oropouche virus, Ct value | Detectable, 16 | Detectable, 8 |
qPCR | ||
Leptospira | Not done | Undetectable |
Neisseria meningitidis | Undetectable | Undetectable |
Streptococcus pneumoniae | Undetectable | Undetectable |
Hemophilus influenzae | Undetectable | Undetectable |
Serology | ||
Dengue virus IgM | Nonreactive | Nonreactive |
Leptospira IgM | Nonreactive | Nonreactive |
Chikungunya virus IgM | Nonreactive | Nonreactive |
Hepatitis C virus IgG, IgM | Not done | Nonreactive |
Hepatitis B virus IgG, IgM | Not done | Nonreactive |
Hepatitis A virus IgG, IgM | Not done | Nonreactive |
*Performed in serum samples, except for Leptospira qPCR, which was performed on whole blood. Patient 1 samples collected 4 days after symptom onset; patient 2 samples collected 5 days after symptom onset. Ct, cycle threshold; qPCR, quantitative PCR; qRT-PCR, quantitative reverse transcription PCR.
Page created: September 10, 2024
Page updated: October 22, 2024
Page reviewed: October 22, 2024
The conclusions, findings, and opinions expressed by authors contributing to this journal do not necessarily reflect the official position of the U.S. Department of Health and Human Services, the Public Health Service, the Centers for Disease Control and Prevention, or the authors' affiliated institutions. Use of trade names is for identification only and does not imply endorsement by any of the groups named above.